Candriam S.C.A. Outset Medical, Inc. Transaction History

Candriam S.C.A.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$12.36 - $26.41 $382,603 - $817,521	-30,955 Reduced 19.86%	124,920 $3.23 Million
Q3 2022 Nov 10, 2022	BUY	$14.67 - $21.7 $548,951 - $812,014	37,420 Added 31.59%	155,875 $2.48 Million
Q1 2022 May 13, 2022	SELL	$34.22 - $47.24 $3,422 - $4,724	-100 Reduced 0.08%	118,455 $5.38 Million
Q3 2021 Nov 09, 2021	BUY	$36.86 - $54.98 $1.14 Million - $1.7 Million	31,000 Added 35.41%	118,555 $5.86 Million
Q2 2021 Jul 20, 2021	BUY	$41.49 - $59.92 $1.5 Million - $2.17 Million	36,212 Added 70.53%	87,555 $4.38 Million

Q4 2020 Jan 22, 2021	BUY	$42.51 - $64.0 $2.18 Million - $3.29 Million	51,343 New	51,343 $2.92 Million

122

41M

63.4K

32.1K

Ticker OM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 48,007,300
Market Cap $181M
Description
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was ...

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

Stay updated on Candriam S.C.A. with notifications on news.